Estimating blood needs for very-low-birth-weight infants

Transfusion

Volumn 46, Issue 11, 2006, Pages 1915-1920

  Fabres, Jorge ^a   Wehrli, Gay ^a   Marques, Marisa B ^a   Phillips, Vivien ^a   Dimmitt, Reed A ^a   Westfall, Andrew O ^a   Schelonka, Robert L ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b 525 New Hillman Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; ERYTHROCYTE VOLUME; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; VERY LOW BIRTH WEIGHT;

BODY WEIGHT; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MALE; NEEDS ASSESSMENT; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 33750311665     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00997.x     Document Type: Article

References (28)

1. Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001;107:E1.
2. Strauss RG. Red blood cell transfusion practices in the neonate. Clin Perinatol 1995;22:641-55.
3. Bifano EM, Curran TR. Minimizing donor blood exposure in the neonatal intensive care unit: current trends and future prospects. Clin Perinatol 1995;22:657-69.
4. Bednarek FJ, Weisberger S, Richardson DK, et al. Variations in blood transfusions among newborn intensive care units. SNAP II Study Group. J Pediatr 1998;133:601-7.
5. Maier RF, Sonntag J, Walka MM, et al. Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g. J Pediatr 2000;136:220-4.
6. Patten E, Robbins M, Vincent J, et al. Use of red blood cells older than five days for neonatal transfusion. J Perinatol 1991;11:37-40.
7. Cook S, Gunter J, Wissel M. Effective use of a strategy using assigned red cell units to limit donor exposure for neonatal patients. Transfusion 1993;33:379-83.
8. Liu EA, Mannino FL, Lane TA. Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates. J Pediatr 1994;125:92-6.
9. Wood A, Wilson N, Skacel P, et al. Reducing donor exposure in preterm infants requiring multiple blood transfusions. Arch Dis Child Fetal Neonatal Ed 1995;72:F29-F33.
10. Lee DA, Slagle TA, Jackson TM, et al. Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packed red blood cells. J Pediatr 1995;126:280-6.
11. Strauss RG. Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and/or recombinant human erythropoietin. Transfus Med Rev 2006;20:34-44.
12. Strauss RG, Burmeister LF, Johnson K, et al. AS-1 red cells for neonatal transfusions: a randomized trial assessing donor exposure and safety. Transfusion 1996;36:873-8.
13. Mangel J, Goldman M, Garcia C, et al. Reduction of donor exposures in premature infants by the use of designated adenine-saline preserved split red blood cell packs. J Perinatol 2001;21:363-7.
14. Hilsenrath P, Nemechek J, Widness JA, et al. Cost-effectiveness of a limited-donor blood program for neonatal red cell transfusions. Transfusion 1999;39:938-43.
15. van Straaten HL, Wildt-Eggen J, Huisveld IA. Evaluation of a strategy to limit blood donor exposure in high risk premature newborns based on clinical estimation of transfusion need. J Perinat Med 2000;28:122-8.
16. Papile LA, Burstein J, Burstein R, et al. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J Pediatr 1978;92:529-34.
17. Wang-Rodriguez J, Mannino FL, Liu E, et al. A novel strategy to limit blood donor exposure and blood waste in multiply transfused premature infants. Transfusion 1996;36:64-70.
18. Widness JA, Seward VJ, Kromer IJ, et al. Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr 1996;129:680-7.
19. Franz AR, Pohlandt F. Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary? Arch Dis Child Fetal Neonatal Ed 2001;84:F96-F100.
20. Maier RF, Obladen M, Scigalla P, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med 1994;330:1173-8.
21. Shannon KM, Keith JF III, Mentzer WC, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995;95:1-8.
22. Bell EF, Strauss RG, Widness JA, et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 2005;115:1685-91.
23. Levy GJ, Strauss RG, Hume H, et al. National survey of neonatal transfusion practices. I. Red blood cell therapy. Pediatrics 1993;91:523-9.
24. Brown MS, Berman ER, Luckey D. Prediction of the need for transfusion during anemia of prematurity. J Pediatr 1990;116:773-8.
25. Kling PJ, Sullivan TM, Leftwich ME, et al. Score for neonatal acute physiology and phlebotomy blood loss predict erythrocyte transfusions in premature infants. Arch Pediatr Adolesc Med 1997;151:27-31.
26. Donowitz LG, Turner RB, Searcy MA, et al. The high rate of blood donor exposure for critically ill neonates. Infect Control Hosp Epidemiol 1989;10:509-10.
27. Alagappan A, Shattuck KE, Malloy MH. Impact of transfusion guidelines on neonatal transfusions. J Perinatol 1998;18:92-7.
28. Beeram MR, Krauss DR, Riggs MW. Red blood cell transfusion practices in very low birth weight infants in 1990s postsurfactant era. J Natl Med Assoc 2001;93:405-9.